- Home
- SIGA vs CLPT Comparison
SIGA vs CLPT Comparison
Compare SIGA & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIGA
- CLPT
- Stock Information
- Founded
- SIGA 1995
- CLPT 1998
- Country
- SIGA United States
- CLPT United States
- Employees
- SIGA N/A
- CLPT N/A
- Industry
- SIGA Biotechnology: Pharmaceutical Preparations
- CLPT Medical/Dental Instruments
- Sector
- SIGA Health Care
- CLPT Health Care
- Exchange
- SIGA Nasdaq
- CLPT Nasdaq
- Market Cap
- SIGA 422.9M
- CLPT 370.8M
- IPO Year
- SIGA 1997
- CLPT N/A
- Fundamental
- Price
- SIGA $6.03
- CLPT $13.93
- Analyst Decision
- SIGA
- CLPT Strong Buy
- Analyst Count
- SIGA 0
- CLPT 3
- Target Price
- SIGA N/A
- CLPT $25.00
- AVG Volume (30 Days)
- SIGA 458.7K
- CLPT 315.3K
- Earning Date
- SIGA 07-31-2025
- CLPT 05-13-2025
- Dividend Yield
- SIGA 9.95%
- CLPT N/A
- EPS Growth
- SIGA N/A
- CLPT N/A
- EPS
- SIGA 0.67
- CLPT N/A
- Revenue
- SIGA $120,330,310.00
- CLPT $32,235,999.00
- Revenue This Year
- SIGA N/A
- CLPT $23.97
- Revenue Next Year
- SIGA $95.31
- CLPT $27.52
- P/E Ratio
- SIGA $8.99
- CLPT N/A
- Revenue Growth
- SIGA N/A
- CLPT 23.22
- 52 Week Low
- SIGA $4.95
- CLPT $5.11
- 52 Week High
- SIGA $12.83
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- SIGA 51.95
- CLPT 59.22
- Support Level
- SIGA $5.86
- CLPT $12.63
- Resistance Level
- SIGA $6.23
- CLPT $13.44
- Average True Range (ATR)
- SIGA 0.23
- CLPT 0.62
- MACD
- SIGA -0.00
- CLPT 0.13
- Stochastic Oscillator
- SIGA 57.14
- CLPT 99.36
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.